Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    David Ritchie

    TitleResident Physician
    SchoolUniversity of California, San Diego
    DepartmentRadiology
    Address200 W. Arbor Drive #8756
    CA San Diego 92103
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Gonzalez MD, McMullen AR, Wallace MA, Crotty MP, Ritchie D, Burnham CA. Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of ß-Lactam-Resistant Gram-Negative Bacteria. Ann Lab Med. 2017 Mar; 37(2):174-176. PMID: 28029009.
        View in: PubMed
      2. Hsueh K, Reyes M, Krekel T, Casabar E, Ritchie D, Jafarzadeh SR, Hays AJ, Lane MA, Durkin MJ. Effective Antibiotic Conservation by Emergency Antimicrobial Stewardship During a Drug Shortage. Infect Control Hosp Epidemiol. 2017 Mar; 38(3):356-359. PMID: 27917734.
        View in: PubMed
      3. Crotty MP, Krekel T, Burnham CA, Ritchie D. New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides. J Clin Microbiol. 2016 Sep; 54(9):2225-32. PMID: 26962092; PMCID: PMC5005494 [Available on 03/01/17].
      4. Crotty MP, Meyers S, Hampton N, Bledsoe S, Ritchie D, Buller RS, Storch GA, Micek ST, Kollef MH. Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study. Medicine (Baltimore). 2015 Dec; 94(50):e2332. PMID: 26683973.
        View in: PubMed
      5. Crotty MP, Meyers S, Hampton N, Bledsoe S, Ritchie D, Buller RS, Storch GA, Kollef MH, Micek ST. Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship. Crit Care. 2015 Nov 18; 19:404. PMID: 26577540; PMCID: PMC4650137.
      6. Ritchie D, Garavaglia-Wilson A. A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections. Clin Infect Dis. 2014 Dec 01; 59 Suppl 6:S374-80. PMID: 25371513.
        View in: PubMed
      7. Ritchie D, Yen ML. Health services management development: what formal knowledge should support the skills and experience required? Aust Health Rev. 2013 May; 37(2):189-93. PMID: 23498856.
        View in: PubMed
      8. Alexander BT, Marschall J, Tibbetts RJ, Neuner EA, Dunne WM, Ritchie D. Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort. Clin Ther. 2012 Jun; 34(6):1314-23. PMID: 22691610; PMCID: PMC4289904.
      9. Marcos LA, Camins BC, Ritchie D, Casabar E, Warren DK. Acute renal insufficiency during telavancin therapy in clinical practice. J Antimicrob Chemother. 2012 Mar; 67(3):723-6. PMID: 22174040.
        View in: PubMed
      10. Pongruangporn M, Ritchie D, Lu D, Marschall J. Vancomycin-associated leukocytoclastic vasculitis. Case Rep Infect Dis. 2011; 2011:356370. PMID: 22567469; PMCID: PMC3336219.
      11. Crank CW, Scheetz MH, Brielmaier B, Rose WE, Patel GP, Ritchie D, Segreti J. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study. Clin Ther. 2010 Sep; 32(10):1713-9. PMID: 21194593.
        View in: PubMed
      12. Alexander BT, Hladnik LM, Augustin KM, Casabar E, McKinnon PS, Reichley RM, Ritchie D, Westervelt P, Dubberke ER. Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients. Pharmacotherapy. 2010 Jun; 30(6):554-61. PMID: 20500045; PMCID: PMC3668347.
      13. Ritchie D, Alexander BT, Finnegan PM. New antimicrobial agents for use in the intensive care unit. Infect Dis Clin North Am. 2009 Sep; 23(3):665-81. PMID: 19665089.
        View in: PubMed
      14. Arnold HM, McKinnon PS, Augustin KM, Hladnik LM, Casabar E, Reichley RM, Dubberke ER, Westervelt P, Ritchie D. Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever. Pharmacotherapy. 2009 Aug; 29(8):914-23. PMID: 19637944; PMCID: PMC4256050.
      15. Neuner EA, Ritchie D, Micek ST. New antibiotics for healthcare-associated pneumonia. Semin Respir Crit Care Med. 2009 Feb; 30(1):92-101. PMID: 19199191.
        View in: PubMed
      16. Deal EN, Micek ST, Reichley RM, Ritchie D. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Clin Ther. 2009 Feb; 31(2):299-310. PMID: 19302902.
        View in: PubMed
      17. Brielmaier BD, Casabar E, Kurtzeborn CM, McKinnon PS, Ritchie D. Early clinical experience with anidulafungin at a large tertiary care medical center. Pharmacotherapy. 2008 Jan; 28(1):64-73. PMID: 18154476.
        View in: PubMed
      18. Daly MW, Riddle DJ, Ledeboer NA, Dunne WM, Ritchie D. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae. Pharmacotherapy. 2007 Jul; 27(7):1052-7. PMID: 17594211.
        View in: PubMed
      19. Deal EN, Micek ST, Ritchie D, Reichley RM, Dunne WM, Kollef MH. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii. Pharmacotherapy. 2007 Feb; 27(2):191-9. PMID: 17253909.
        View in: PubMed
      20. Jeffres MN, Isakow W, Doherty JA, McKinnon PS, Ritchie D, Micek ST, Kollef MH. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest. 2006 Oct; 130(4):947-55. PMID: 17035423.
        View in: PubMed
      21. Wilson AG, Micek ST, Ritchie D. A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia. Clin Ther. 2005 Aug; 27(8):1228-37. PMID: 16199247.
        View in: PubMed
      22. Micek ST, Lloyd AE, Ritchie D, Reichley RM, Fraser VJ, Kollef MH. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother. 2005 Apr; 49(4):1306-11. PMID: 15793102; PMCID: PMC1068618.
      23. Burleson BS, Ritchie D, Micek ST, Dunne WM. Enterococcus faecalis resistant to linezolid: case series and review of the literature. Pharmacotherapy. 2004 Sep; 24(9):1225-31. PMID: 15460184.
        View in: PubMed
      24. Qaqish RB, Mattes KA, Ritchie D. Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection. Clin Ther. 2003 Dec; 25(12):3084-99. PMID: 14749147.
        View in: PubMed
      25. Zervos MJ, Hershberger E, Nicolau DP, Ritchie D, Blackner LK, Coyle EA, Donnelly AJ, Eckel SF, Eng RH, Hiltz A, Kuyumjian AG, Krebs W, McDaniel A, Hogan P, Lubowski TJ. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis. 2003 Dec 15; 37(12):1643-8. PMID: 14689346.
        View in: PubMed
      26. Barnes BJ, Wiederhold NP, Micek ST, Polish LB, Ritchie D. Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literature. Pharmacotherapy. 2003 Apr; 23(4):537-42. PMID: 12680484.
        View in: PubMed
      27. Mondy KE, Haughey B, Custer PL, Wippold FJ, Ritchie D, Mundy LM. Rhinocerebral mucormycosis in the era of lipid-based amphotericin B: case report and literature review. Pharmacotherapy. 2002 Apr; 22(4):519-26. PMID: 11939688.
        View in: PubMed
      28. Babcock HM, Ritchie D, Christiansen E, Starlin R, Little R, Stanley S. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid. Clin Infect Dis. 2001 May 01; 32(9):1373-5. PMID: 11303275.
        View in: PubMed
      29. McMullin ST, Hennenfent JA, Ritchie D, Huey WY, Lonergan TP, Schaiff RA, Tonn ME, Bailey TC. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999 Oct 25; 159(19):2306-9. PMID: 10547170.
        View in: PubMed
      30. Bailey TC, Ritchie D, McMullin ST, Kahn M, Reichley RM, Casabar E, Shannon W, Dunagan WC. A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions. Pharmacotherapy. 1997 Mar-Apr; 17(2):277-81. PMID: 9085319.
        View in: PubMed
      31. Reichley RM, Ritchie D, Bailey TC. Analysis of various creatinine clearance formulas in predicting gentamicin elimination in patients with low serum creatinine. Pharmacotherapy. 1995 Sep-Oct; 15(5):625-30. PMID: 8570436.
        View in: PubMed
      32. Jett BD, Ritchie D, Reichley R, Bailey TC, Sahm DF. In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins. Antimicrob Agents Chemother. 1995 May; 39(5):1187-90. PMID: 7625813; PMCID: PMC162708.
      33. Aguilar HE, Meredith TA, el-Massry A, Shaarawy A, Kincaid M, Dick J, Ritchie D, Reichley RM, Neisman MK. Vancomycin levels after intravitreal injection. Effects of inflammation and surgery. Retina. 1995; 15(5):428-32. PMID: 8594637.
        View in: PubMed
      34. Shaarawy A, Meredith TA, Kincaid M, Dick J, Aguilar E, Ritchie D, Reichley RM. Intraocular injection of ceftazidime. Effects of inflammation and surgery. Retina. 1995; 15(5):433-8. PMID: 8594638.
        View in: PubMed
      35. Ritchie D, Becker ES. Update on the management of intestinal cryptosporidiosis in AIDS. Ann Pharmacother. 1994 Jun; 28(6):767-78. PMID: 7919569.
        View in: PubMed
      36. Ritchie D, Reichley RM, Canaday KL, Bailey TC. Evaluation and financial impact of imipenem/cilastatin dosing in elderly patients based on renal function and body weight. J Pharm Technol. 1993 Jul-Aug; 9(4):160-3. PMID: 10128045.
        View in: PubMed
      37. Fichtenbaum CJ, Ritchie D, Powderly WG. Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS. Clin Infect Dis. 1993 Feb; 16(2):298-300. PMID: 8443313.
        View in: PubMed
      38. Ritchie D, Hopefl AW, Milligan TW, Byrne JE, Maddux MS. In vitro activity of clarithromycin, cefprozil, and other common oral antimicrobial agents against gram-positive and gram-negative pathogens. Clin Ther. 1993 Jan-Feb; 15(1):107-13. PMID: 8458040.
        View in: PubMed
      39. Ritchie D, Manchester RF, Rich MW, Rockwell MM, Stein PM. Acceptance of a pharmacy-based, physician-edited hospital pharmacy and therapeutics committee newsletter. Ann Pharmacother. 1992 Jul-Aug; 26(7-8):886-9. PMID: 1504393.
        View in: PubMed
      40. Ritchie D, Holstad SG, Westrich TJ, Hirsch JD, O'Dorisio TM. Activity of octreotide acetate in a total nutrient admixture. Am J Hosp Pharm. 1991 Oct; 48(10):2172-5. PMID: 1781474.
        View in: PubMed
      41. Binder EF, Cayabyab L, Ritchie D, Birge SJ. Diltiazem-induced psychosis and a possible diltiazem-lithium interaction. Arch Intern Med. 1991 Feb; 151(2):373-4. PMID: 1899553.
        View in: PubMed